Key Market Indicators
Serbia's expenditure on medical products is projected to hit €1.38 billion by 2028, up from €1.15 billion in 2023. This marks an average annual growth rate of 2.7%. Since the turn of the century, Serbia's demand for medical products has surged at an average rate of 10.3% per year. In the current year, Serbia holds the 22nd spot in global rankings for medical product expenditure. Lithuania narrowly surpasses Serbia with an expenditure of €1.15 billion. Leading the rankings are France, the United Kingdom, and Poland, occupying the second, third, and fourth positions respectively.
